Contact this trialFirst, we need to learn more about you.
Anti-sense oligonucleotide
Fazirsiran for Alpha-1 Antitrypsin Deficiency
Recruiting1 awardPhase 3
Ann Arbor, Michigan
This trial is studying a medication called fazirsiran in people with a liver disease caused by an abnormal protein called Z-AAT. The medication aims to reduce the build-up of this abnormal protein in the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service